NCT00589329 arm group 9d5ed678fe57bcca610140957afab571 [clinicaltrials_resource:NCT00589329/arm-group/9d5ed678fe57bcca610140957afab571]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00589329 arm group 9d5ed678fe57bcca610140957afab571 [clinicaltrials_resource:NCT00589329/arm-group/9d5ed678fe57bcca610140957afab571]
Bio2RDF identifier
NCT00589329/arm-group/9d5ed678fe57bcca610140957afab571
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 5ed678fe57bcca610140957afab571
description [clinicaltrials_vocabulary:description]
Group B will not receive antib ...... (IV saline and pill) regimen.
identifier
clinicaltrials_resource:NCT00589329/arm-group/9d5ed678fe57bcca610140957afab571
title
NCT00589329 arm group 9d5ed678fe57bcca610140957afab571
@en
type
label
NCT00589329 arm group 9d5ed678 ...... ed678fe57bcca610140957afab571]
@en